Search Results

You are looking at 1 - 10 of 538 items for :

  • "thyroid cancer" x
Clear All
Free access

Weijun Wei, Heather Hardin and Quan-Yong Luo

Introduction Thyroid cancer is the fifth most common cancer in women in the United States and is the most commonly diagnosed cancer before the age of 30 years among women in China ( Chen et al. 2016 ). Although thyroid cancer is generally

Free access

Carles Zafon, Joan Gil, Beatriz Pérez-González and Mireia Jordà

Introduction Thyroid cancer, the most prevalent endocrine malignancy, covers the full range of phenotypes from indolent to the worst forms of human cancer. It is categorized into differentiated thyroid cancer (DTC), poorly differentiated

Free access

Hao Fu, Lin Cheng, Yuchen Jin and Libo Chen

thyroid carcinoma. With globally rising incidence, thyroid carcinoma has attracted much more concern than before. In theory, thyrotoxicosis with suppressed TSH should lead to a lower incidence of thyroid cancer than that observed in euthyroid patients

Open access

Xianhui Ruan, Xianle Shi, Qiman Dong, Yang Yu, Xiukun Hou, Xinhao Song, Xi Wei, Lingyi Chen and Ming Gao

Introduction Thyroid cancer is the most common cancer of endocrine system, with a rapid worldwide increase over recent decades ( Enewold et al. 2009 , Kilfoy et al. 2009 , Chen et al. 2016 ). The disease is classified into three types

Free access

Christopher W Rowe, Jonathan W Paul, Craig Gedye, Jorge M Tolosa, Cino Bendinelli, Shaun McGrath and Roger Smith

differentiated thyroid cancer (DTC), TSHR is therapeutically targeted to maximize radioiodine uptake into malignant thyrocytes by transiently upregulating the sodium–iodide symporter (NIS) through TSH stimulation, either endogenously through thyroid hormone

Free access

Rengyun Liu and Mingzhao Xing

glioblastoma ( Killela et al . 2013 , Liu et al . 2013 a ) as well as thyroid cancer ( Liu et al . 2013 b ). There are two common recurrent TERT promoter mutations in human cancer that are located at two hotspots: chr5, 1,295,228 C>T (C228T) and 1

Free access

Susan J Hsiao and Yuri E Nikiforov

Introduction Among endocrine tumors, thyroid cancer is the most common, with an estimated incidence of 12.2/100 000 per year in the USA ( Howlader et al . 2013 ). The incidence of thyroid cancer, both in the USA and worldwide, has been increasing

Free access

Athanasios Bikas, Kirk Jensen, Aneeta Patel, John Costello Jr, Dennis McDaniel, Joanna Klubo-Gwiezdzinska, Olexander Larin, Victoria Hoperia, Kenneth D Burman, Lisa Boyle, Leonard Wartofsky and Vasyl Vasko

). In cell lines derived from follicular and papillary thyroid cancers, metformin inhibited cell growth, activated AMPK, down-regulated p70S6K/pS6 signaling, antagonized the growth-stimulatory effects of insulin, inhibited clonal cell growth, and reduced

Free access

Valtter B Virtanen, Eero Pukkala, Reetta Kivisaari, Perttu P Salo, Antti Koivusalo, Johanna Arola, Päivi J Miettinen, Risto J Rintala, Markus Perola and Mikko P Pakarinen

, which are caused by a germline mutation and associate with MTC, somatic gene rearrangements of the RET gene are associated with papillary thyroid cancer ( Grieco et al . 1990 ). The incidence of MTC has been reported to vary between 2.5 and 5% among

Restricted access

Ryan K Orosco, Timon Hussain, Julia E Noel, David C Chang, Chrysoula Dosiou, Erik Mittra, Vasu Divi and Lisa A Orloff

Introduction Thyroid cancer is the most common new malignancy diagnosed in the United States. It also carries an expanding global disease burden, in part due to the increased detection of tumors that may otherwise remain asymptomatic and not